2022
DOI: 10.1039/d1en01127h
|View full text |Cite
|
Sign up to set email alerts
|

Using AOP-Wiki to support the ecotoxicological risk assessment of nanomaterials: first steps in the development of novel adverse outcome pathways

Abstract: Currently, the development of Adverse Outcome Pathways (AOPs) that are relevant for nanomaterials (NMs) is focusing mainly on their human toxicity. However, there is an additional component of nanosafety that...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 26 publications
(41 reference statements)
0
2
0
Order By: Relevance
“…To date, the majority of AOP-building effort has been focussed in human health and mammalian studies, but the application of AOPs for model organisms such as Daphnia is increasingly being investigated (Song et al, 2020). While in principle AOPs are chemical-agnostic, and focussed more on mechanisms, such as endocrine disruption or ion-channel blocking, for example, work is underway to establish NMs-specific AOPs, focussing on key aspects such as NMs-biomolecule interactions, NM-membrane interactions, and NMs-induced disruption of enzyme activity, for example, Jagiello et al found that only 8 of 331 available AOPs in the AOP-Wiki are specific for NMs (namely,AOP numbers 144,173,207,208,209,210,241,and 319), meaning that only 2.4% of all AOPs in the AOP-Wiki have (as of 2022) been assessed or considered for their direct relevance to NMs, and thus there is a need to evaluate whether remaining AOPs might be applicable fully or partially to NMs (Jagiello et al, 2022).…”
Section: Adverse Outcome Pathways-gaps In Terms Of Ecotoxicity and Nmsmentioning
confidence: 99%
“…To date, the majority of AOP-building effort has been focussed in human health and mammalian studies, but the application of AOPs for model organisms such as Daphnia is increasingly being investigated (Song et al, 2020). While in principle AOPs are chemical-agnostic, and focussed more on mechanisms, such as endocrine disruption or ion-channel blocking, for example, work is underway to establish NMs-specific AOPs, focussing on key aspects such as NMs-biomolecule interactions, NM-membrane interactions, and NMs-induced disruption of enzyme activity, for example, Jagiello et al found that only 8 of 331 available AOPs in the AOP-Wiki are specific for NMs (namely,AOP numbers 144,173,207,208,209,210,241,and 319), meaning that only 2.4% of all AOPs in the AOP-Wiki have (as of 2022) been assessed or considered for their direct relevance to NMs, and thus there is a need to evaluate whether remaining AOPs might be applicable fully or partially to NMs (Jagiello et al, 2022).…”
Section: Adverse Outcome Pathways-gaps In Terms Of Ecotoxicity and Nmsmentioning
confidence: 99%
“…Although at present, the development of NM-related adverse outcome pathways has mainly focused on human toxicity, an additional nanosafety component to consider in risk assessment of this class of material is eco-toxicity [8]. The unique physicochemical properties of NMs enable them to interact with biomolecules and change essential biochemical pathways.…”
Section: Introductionmentioning
confidence: 99%